MINDCURE to Webcast Live at the KCSA Psychedelics Virtual Investor Conference on October 13, 2021
MINDCURE invites investors and analysts to a live presentation on October 13, 2021, at 12:00 PM ET via VirtualInvestorConferences.com. President & CEO Kelsey Ramsden will discuss the company's advancements in psychedelic research and digital therapeutics aimed at enhancing mental health. An archived webcast will be available for those unable to attend live. Pre-registration is recommended to improve participation. MINDCURE operates in the life sciences sector, focusing on evidence-based healing methods.
- None.
- None.
MINDCURE invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on VirtualInvestorConferences.com
VANCOUVER, BC, Oct. 7, 2021 /PRNewswire/ - Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) ("MINDCURE" or the "Company"), a leader in advanced proprietary technology and research for psychedelics, today announced that President & Chief Executive Officer, Kelsey Ramsden will present virtually at the KCSA Psychedelics Investor Conference on Wednesday, October 13, 2021, which will be held at VirtualInvestorConferences.com.
DATE: October 13, 2021
TIME: 12:00pm ET
LINK: https://bit.ly/3kObcQO
This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event. It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates.
Learn more about the event at www.virtualinvestorconferences.com.
About Mind Cure Health Inc.
MINDCURE is a life sciences company focused on innovating and commercializing new ways to promote healing and improve mental health. The company is developing digital therapeutics technology and researching psychedelic compounds to support access to safe, evidence-based psychedelic-assisted therapies globally. Learn more at mindcure.com, and follow us on LinkedIn, Facebook, Twitter, and Instagram.
On Behalf of the Board of Directors
Kelsey Ramsden, President & CEO
Phone: 1-888-593-8995
Forward-Looking Information
Certain information presented in this news release may constitute "forward-looking information" within the meaning of applicable securities laws regarding MINDCURE and its business. Forward-looking information generally can be identified by the use of terms and phrases such as "anticipate", "believe", "could", "estimate", "expect", "feel", "intend", "may", "plan", "predict", "project", "subject to", "will", "would", and similar terms and phrases.
Forward-looking information is based on a number of key expectations and assumptions made by management of MINDCURE, including, without limitation: the COVID-19 pandemic impact on the Canadian economy and MINDCURE's business, and the extent and duration of such impact; no change to laws or regulations that negatively affect MINDCURE's business; the Company will develop its products as expected and that they will attain the outcomes anticipated; there will be a demand for MINDCURE's products in the future; no unanticipated expenses or costs arise; MINDCURE will be able to continue to identify products that make them ideal candidates for providing solutions for treating mental health; that strategic partnerships entered by the Company will create the opportunities and outcomes anticipated; that MINDCURE will advance wellness worldwide; that trading on the OTCQX will attract additional investment and provide additional liquidity for shareholders.
Forward-looking information is provided for the purpose of presenting information about management's current expectations and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. Forward-looking information inherently entails known and unknown risks and uncertainties about the future and actual results and involves significant risks and uncertainties and should not be read as a guarantee of future performance or results as actual results may differ materially from those expressed or implied in such forward-looking information. Those risks and uncertainties include, among other things, risks related to: trading on the OTCQX enhancing the visibility of MINDCURE and its strategic growth objectives to a larger subset of the investment community, while materially increasing its share liquidity and capturing additional capital markets attention to facilitate growth initiatives and deliver long-term shareholder value. Although MINDCURE has attempted to identify important factors that could cause actual results, performance or achievements to differ materially from those described in forward-looking information presented, there may be other factors that cause results, performance or achievements to differ from those anticipated, estimated or intended. Accordingly, readers should not place undue reliance on any forward-looking statements as no forward-looking information can be guaranteed.
Except as required by applicable securities laws, forward-looking statements speak only as of the date on which they are made and MINDCURE does not undertake any obligation to publicly update or revise any forward-looking information, whether as a result of new information, future events, or otherwise.
The CSE has neither approved nor disapproved the contents of this press release and the CSE does not accept responsibility for the adequacy or accuracy of this release.
View original content to download multimedia:https://www.prnewswire.com/news-releases/mindcure-to-webcast-live-at-the-kcsa-psychedelics-virtual-investor-conference-on-october-13-2021-301394915.html
SOURCE Mind Cure Health Inc.
FAQ
When is the MINDCURE presentation at the KCSA Psychedelics Investor Conference?
How can I attend the MINDCURE conference presentation?
Who is the CEO of MINDCURE?
What will MINDCURE discuss during the conference?
Is there a link available for the MINDCURE conference?
Will there be a recording of the MINDCURE presentation?
